Ibrutinib in Anti-MAG Neuropathy with Waldenstrom Macroglobulinemia

被引：0
|
作者：
Mahuwala, Zabeen [1 ]
Kumaraswamy, Vishakhadatta Mathur [2 ]
Ajjeya, Mangayarkarasi Thandampallayam [3 ]
Pervin, Saniya [3 ]
机构：
[1] Univ Kentucky, Neurol, KY Clin Neurol Dept, Lexington, KY USA
[2] Univ Kentucky, Lexington, KY USA
[3] Univ Kentucky, Neurol, Lexington, KY USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202717
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P10-5.010
引用
收藏
页数：3
相关论文
共 50 条
  • [21] ANTI-MAG NEUROPATHY: ELECTROPHYSIOLOGICAL INSIGHTS INTO PATHOPHYSIOLOGY
    Cassano, Emanuele
    Tozza, Stefano
    Di Sarno, Isabella
    Spina, Emanuele
    Palumbo, Giovanni
    Iodice, Rosa
    Nolano, Maria
    Manganelli, Fiore
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S11 - S12
  • [22] SELECTIVE IN VIVO REMOVAL OF PATHOGENIC ANTI-MAG AUTOANTIBODIES: A NOVEL TREATMENT OPTION FOR ANTI-MAG NEUROPATHY
    Herrendorff, R.
    Hanggi, P.
    Pfister, H.
    Yang, F.
    Demeestere, D.
    Hunziker, F.
    Frey, S.
    Schaeren-Wiemers, N.
    Steck, A. J.
    Ernst, B.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 299 - 299
  • [23] Peripheral neuropathy overlapping anti-MAG and multifocal motor neuropathy
    Kurian, M.
    Lalive, P. H.
    Magistris, M.
    Andreas, S.
    Horvath, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 287 - 287
  • [24] DO ANTI-MAG TITERS HAVE A GOOD CORRELATION WITH CLINICAL STATUS IN IGM ANTI-MAG NEUROPATHY?
    Neil, J.
    Ashtiani, Haghi B.
    Choumet, V
    Musset, L.
    Leger, J. M.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 345 - 345
  • [25] Anti-MAG titers pre/post deglycosylation in patients with anti-MAG neuropathy: Clinicopathological correlation in 8 cases
    Leger, Jean-Marc
    Beadon, Katie
    Neil, Jean
    Delmont, Emilien
    Haghi, B.
    Musset, L.
    Attarian, S.
    Boucraut, Joseph
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 337 - 337
  • [26] Ibrutinib in the management of Waldenstrom macroglobulinemia
    Yosef, Amir
    Touloukian, Emily Z.
    Nambudiri, Vinod E.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (02) : 434 - 441
  • [27] The role of ibrutinib in Waldenstrom macroglobulinemia
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Kastritis, Efstathios
    Dimopoulos, Meletios Athanasios
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (01): : 85 - 89
  • [28] Clinical and immunological worsening in a patient affected with waldestrom macroglobulinemia and anti-mag neuropathy after treatment with rituximab
    Gironi, M.
    Saresella, M.
    Ceresa, L.
    Calvo, M.
    Ferrante, P.
    Merli, F.
    Nemni, R.
    HAEMATOLOGICA, 2006, 91 : 51 - 52
  • [29] WALDENSTROM MACROGLOBULINEMIA IN RELAXATION AND IBRUTINIB
    Morales Ruiz, Y.
    Lemes Quintana, C.
    Gomez Casares, M. T.
    Marrero Quintana, M. T.
    Guedes Mesa, S.
    Mohamed Abdelfatah, S.
    Romero Khoury, C.
    Bosch Benitez, J. M.
    Gonzalez San Miguel, J. D.
    HAEMATOLOGICA, 2019, 104 : 392 - 392
  • [30] Ibrutinib for the treatment of Waldenstrom macroglobulinemia
    Chakraborty, Rajshekhar
    Kapoor, Prashant
    Ansell, Stephen M.
    Gertz, Morie A.
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (05) : 569 - 579
12345